D. Medical Industries Ltd. (DMED) Moves to Obtain CE Mark Approval for its Revolutionary Spring Zone Insulin Pump
D. Medical Industries, via its subsidiaries, is a constant innovator in cutting-edge medical devices sector for the delivery of diabetes treatments and other drugs. Today the Company announced submission of an application for CE Mark approval through its wholly owned Spring Health Solution Ltd subsidiary for the Spring™ Zone Insulin Delivery System. The Spring Zone is a full replacement for generation one of the Company’s Spring ADI insulin pump and incorporates the proprietary Intellispring™ technology, resulting in vastly superior performance advantages in blockage, detachment direction, continuous insulin delivery checking and pressure/temp-related environmental adaptability. Also utilized in the product is the…